1Collie-Duguid ES, Pritchard SC, Powrie RH, et al. The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations. Pharmacogenetics, 1999, 9: 37-42.
2McLeod HL, Pritchard SC, Githang′a J, et al. Ethnic differences in thiopurine methyltransferase pharmacogenetics: evidence for allele specificity in Caucasian and Kenyan individuals. Pharmacogenetics, 1999, 9: 773-776.
3Hon YY, Fessing MY, Pui CH, et al. Polymorphism of the thiopurine S-methyltransferase gene in African-Americans.Hum Mol Genet, 1999,8: 371-376.
4Ameyaw MM, Collie-Duguid ES, Powrie RH, et al. Thiopurine methyltransferase alleles in British and Ghanaian populations. Hum Mol Genet, 1999,8: 367-370.
5Spire-Vayron de la Moureyre C, Debuysere H, Mastain B,et al. Genotypic and phenotypic analysis of the polymorphic thiopurine S-methyltransferase gene (TPMT) in a European population. Br J Pharmacol,1998, 125: 879-887.
6Kubota T, Chiba K. Frequencies of thiopurine S-methyltransferase mutant alleles (TPMT*2, *3A, *3B and *3C) in 151 healthy Japanese subjects and the inheritance of TPMT*3C in the family of a propositus. Br J Clin Pharmacol, 2001, 51: 475-477.
7Kumagai K, Hiyama K, Ishioka S, et al. Allelotype frequency of the thiopurine methyltransferase (TPMT) gene in Japanese. Pharmacogenetics, 2001,11: 275-278.
8Spire-Vayron de la Moureyre C, Debuysere H,Fazio F, et al. Characterization of a variable number tandem repeat region in the thiopurine S-methyltransferase gene promoter. Pharmacogene-tics, 1999, 9: 189-198.
9Fessing MY, Krynetski EY, Zambetti GP, et al. Functional characterization of the human thiopurine S-methyltransferase (TPMT) gene promoter. Eur J Biochem, 1998, 256: 510-517.
